Publications from VelaLabs experts

Surface Plasmon Reso­nance for Deter­mi­na­tion of Potency.

Gaderer, S. (2022). Pharm. Ind. 84, Nr. 7, 909 – 917 (2022) © ECV • Editio Cantor Verlag, Aulen­dorf (Germany).

READ FULL ARTICLE HERE

Insight into biosim­i­lars: Short descrip­tion, analyt­ical assess­ment and market.

Zimmer­mann, K, Fido, M, and Roucka, M. (2020). Medical Research Archives 8: issue 3.

READ FULL ARTICLE HERE

Glyco­sy­la­tion pattern of biotech­no­log­i­cally produced proteins – lectin array tech­nology as a versa­tile tool for screening?

Zimmer­mann, K, Fido, M, and Roucka, M. (2018). Medical Research Archives 6: issue 3.

READ FULL ARTICLE HERE

Appli­ca­tion of lectin array tech­nology for biobetter char­ac­ter­i­za­tion: its corre­la­tion with FcγRIII binding and ADCC. Microarrays.

Roucka, M, Zimmer­mann, K, Fido, M, and Nechansky, A. (2017). 6:1.

READ FULL ARTICLE HERE

Intro­duc­tion of the hybcell-based compact sequencing tech­nology and compar­ison to state-of-the-art method­olo­gies for KRAS muta­tion detection.

Zopf, A, Raim, R, Danzer, M, Niklas, N, Spilka, R, Pröll, J, Gabriel, C, Nechansky, A, and Roucka, M. (2015). Biotech­niques. 58:126 – 134.

READ FULL ARTICLE HERE

Corre­la­tion of ADCC activity with cytokine release induced by the stably expressed, glyco-engi­neered human­ized Lewis Y‑specific mono­clonal anti­body MB314.

Kircheis, R, Halanek, N, Koller, I, Jost, W, Schuster, M, Gorr, G, Hajszan, K, and Nechansky, A. (2012). MAbs. 4:532 – 541.

READ FULL ARTICLE HERE

Immuno­genicity of ther­a­peu­tics: a matter of effi­cacy and safety.

Nechansky, A, and Kircheis R. (2010). Drug Discov. 5:1 – 13.

READ ABSTRACT HERE

Measuring the immuno­genicity (human anti-human anti­body response) induced by human­ized mono­clonal anti­bodies applying ELISA and SPR technology.

Nechansky, A. (2010). HAHA – nothing to laugh about. J. Pharm. Biomed. Anal. 51:252 – 254.

READ ABSTRACT HERE

For reprints please contact us HERE

We Value Your Privacy
We use cookies on our website. Some of them are essential, while others help us to analyze how this website is being used and to allow you to contact us through our website, i.e. use the chat widget. You can change your decision at any time.
Privacy Settings
Statistics
We use these technologies to analyze how this website is being used.
Name Google Analytics, Google Tag Manager
Provider Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland
Purpose Cookie by Google used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy https://policies.google.com/privacy
Cookie Name _ga, _gat, _gid
Cookie Expiry 2 years

 

Name LinkedIn Corporation
Provider LinkedIn Corporation, 605 W Maude Ave, Sunnyvale, CA 94085, USA
Purpose Cookie by LinkedIn used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy https://www.linkedin.com/legal/privacy-policy
Cookie Name
Cookie Expiry 2 years
Customer Interaction
These technologies will allow you to contact us through our website, i.e. use the chat widget.
Name LiveChat
Provider LiveChat Software S.A., ul. Zwycięska 47, 53-033 Wroclaw, Poland
Purpose Communication with clients via online chat using the API of the chat service LiveChat.
Privacy Policy https://www.livechat.com/legal/privacy-policy/
Cookie Name __lc_cid, __lc_cst
Cookie Expiry 2 years
Essential
Technologies required to enable the core functionality of this website.
Name Cookie Consent
Provider Owner of this website, Imprint
Purpose Saves the visitors preferences selected in the cookie banner.
Cookie Name ws_cookie_consent
Cookie Expiry 1 year